279 related articles for article (PubMed ID: 33371492)
1. Variations in BK Polyomavirus Immunodominant Large Tumor Antigen-Specific 9mer CD8 T-Cell Epitopes Predict Altered HLA-Presentation and Immune Failure.
Leuzinger K; Kaur A; Wilhelm M; Hirsch HH
Viruses; 2020 Dec; 12(12):. PubMed ID: 33371492
[TBL] [Abstract][Full Text] [Related]
2. Characterization of Immunodominant BK Polyomavirus 9mer Epitope T Cell Responses.
Cioni M; Leboeuf C; Comoli P; Ginevri F; Hirsch HH
Am J Transplant; 2016 Apr; 16(4):1193-206. PubMed ID: 26663765
[TBL] [Abstract][Full Text] [Related]
3. Clinically Relevant Reactivation of Polyomavirus BK (BKPyV) in HLA-A02-Positive Renal Transplant Recipients Is Associated with Impaired Effector-Memory Differentiation of BKPyV-Specific CD8+ T Cells.
van Aalderen MC; Remmerswaal EB; Heutinck KM; Ten Brinke A; Feltkamp MC; van der Weerd NC; van der Pant KA; Bemelman FJ; van Lier RA; Ten Berge IJ
PLoS Pathog; 2016 Oct; 12(10):e1005903. PubMed ID: 27723787
[TBL] [Abstract][Full Text] [Related]
4. Molecular Characterization of BK Polyomavirus Replication in Allogeneic Hematopoietic Cell Transplantation Patients.
Leuzinger K; Kaur A; Wilhelm M; Frank K; Hillenbrand CA; Weissbach FH; Hirsch HH
J Infect Dis; 2023 Apr; 227(7):888-900. PubMed ID: 36409589
[TBL] [Abstract][Full Text] [Related]
5. Reduced Risk of BK Polyomavirus Infection in HLA-B51-positive Kidney Transplant Recipients.
Wunderink HF; Haasnoot GW; de Brouwer CS; van Zwet EW; Kroes ACM; de Fijter JW; Rotmans JI; Claas FHJ; Feltkamp MCW
Transplantation; 2019 Mar; 103(3):604-612. PubMed ID: 30048396
[TBL] [Abstract][Full Text] [Related]
6. BK Polyomavirus-Specific 9mer CD8 T Cell Responses Correlate With Clearance of BK Viremia in Kidney Transplant Recipients: First Report From the Swiss Transplant Cohort Study.
Leboeuf C; Wilk S; Achermann R; Binet I; Golshayan D; Hadaya K; Hirzel C; Hoffmann M; Huynh-Do U; Koller MT; Manuel O; Mueller NJ; Mueller TF; Schaub S; van Delden C; Weissbach FH; Hirsch HH;
Am J Transplant; 2017 Oct; 17(10):2591-2600. PubMed ID: 28326672
[TBL] [Abstract][Full Text] [Related]
7. HLA-A01-, -A03-, and -A024-binding nanomeric epitopes in polyomavirus BK large T antigen.
Ramaswami B; Popescu I; Macedo C; Metes D; Bueno M; Zeevi A; Shapiro R; Viscidi R; Randhawa PS
Hum Immunol; 2009 Sep; 70(9):722-8. PubMed ID: 19446588
[TBL] [Abstract][Full Text] [Related]
8. BK Polyomavirus-specific T cell immune responses in kidney transplant recipients diagnosed with BK Polyomavirus-associated nephropathy.
Bruminhent J; Srisala S; Klinmalai C; Pinsai S; Watcharananan SP; Kantachuvesiri S; Hongeng S; Apiwattanakul N
BMC Infect Dis; 2019 Nov; 19(1):974. PubMed ID: 31744480
[TBL] [Abstract][Full Text] [Related]
9. BK Polyomavirus-Specific CD8 T-Cell Expansion In Vitro Using 27mer Peptide Antigens for Developing Adoptive T-Cell Transfer and Vaccination.
Wilhelm M; Kaur A; Wernli M; Hirsch HH
J Infect Dis; 2021 Apr; 223(8):1410-1422. PubMed ID: 32857163
[TBL] [Abstract][Full Text] [Related]
10. BKV and JCV large T antigen-specific CD8+ T cell response in HLA A*0201+ kidney transplant recipients with polyomavirus nephropathy and patients with progressive multifocal leukoencephalopathy.
Chen Y; Trofe J; Gordon J; Autissier P; Woodle ES; Koralnik IJ
J Clin Virol; 2008 Jun; 42(2):198-202. PubMed ID: 18295538
[TBL] [Abstract][Full Text] [Related]
11. Inefficient cross-presentation limits the CD8+ T cell response to a subdominant tumor antigen epitope.
Otahal P; Hutchinson SC; Mylin LM; Tevethia MJ; Tevethia SS; Schell TD
J Immunol; 2005 Jul; 175(2):700-12. PubMed ID: 16002665
[TBL] [Abstract][Full Text] [Related]
12. Distinct Escape Pathway by Hepatitis C Virus Genotype 1a from a Dominant CD8+ T Cell Response by Selection of Altered Epitope Processing.
Walker A; Skibbe K; Steinmann E; Pfaender S; Kuntzen T; Megger DA; Groten S; Sitek B; Lauer GM; Kim AY; Pietschmann T; Allen TM; Timm J
J Virol; 2016 Jan; 90(1):33-42. PubMed ID: 26446603
[TBL] [Abstract][Full Text] [Related]
13. BK polyomavirus-specific antibody and T-cell responses in kidney transplantation: update.
Kaur A; Wilhelm M; Wilk S; Hirsch HH
Curr Opin Infect Dis; 2019 Dec; 32(6):575-583. PubMed ID: 31567736
[TBL] [Abstract][Full Text] [Related]
14. Amino Acid Substitutions within HLA-B*27-Restricted T Cell Epitopes Prevent Recognition by Hepatitis Delta Virus-Specific CD8
Karimzadeh H; Kiraithe MM; Kosinska AD; Glaser M; Fiedler M; Oberhardt V; Salimi Alizei E; Hofmann M; Mok JY; Nguyen M; van Esch WJE; Budeus B; Grabowski J; Homs M; Olivero A; Keyvani H; Rodríguez-Frías F; Tabernero D; Buti M; Heinold A; Alavian SM; Bauer T; Schulze Zur Wiesch J; Raziorrouh B; Hoffmann D; Smedile A; Rizzetto M; Wedemeyer H; Timm J; Antes I; Neumann-Haefelin C; Protzer U; Roggendorf M
J Virol; 2018 Jul; 92(13):. PubMed ID: 29669837
[TBL] [Abstract][Full Text] [Related]
15. BK Polyomavirus-specific T Cells as a Diagnostic and Prognostic Marker for BK Polyomavirus Infections After Pediatric Kidney Transplantation.
Ahlenstiel-Grunow T; Sester M; Sester U; Hirsch HH; Pape L
Transplantation; 2020 Nov; 104(11):2393-2402. PubMed ID: 31985731
[TBL] [Abstract][Full Text] [Related]
16. CD8
Qiu C; Xiao C; Wang Z; Zhu G; Mao L; Chen X; Gao L; Deng J; Su J; Su H; Fang EF; Zhang ZJ; Zhang J; Xie C; Yuan J; Luo OJ; Huang LA; Wang P; Chen G
Front Immunol; 2021; 12():764949. PubMed ID: 35116022
[TBL] [Abstract][Full Text] [Related]
17. Variant morphology and random chromosomal integration of BK polyomavirus in posttransplant urothelial carcinomas.
Bertz S; Ensser A; Stoehr R; Eckstein M; Apel H; Mayr D; Buettner-Herold M; Gaisa NT; Compérat E; Wullich B; Hartmann A; Knöll A
Mod Pathol; 2020 Jul; 33(7):1433-1442. PubMed ID: 32047230
[TBL] [Abstract][Full Text] [Related]
18. Discovery of immunodominant T-cell epitopes reveals penton protein as a second immunodominant target in human adenovirus infection.
Tischer S; Geyeregger R; Kwoczek J; Heim A; Figueiredo C; Blasczyk R; Maecker-Kolhoff B; Eiz-Vesper B
J Transl Med; 2016 Oct; 14(1):286. PubMed ID: 27717382
[TBL] [Abstract][Full Text] [Related]
19. Identification of Immunodominant HIV-1 Epitopes Presented by HLA-C*12:02, a Protective Allele, Using an Immunopeptidomics Approach.
Chikata T; Paes W; Akahoshi T; Partridge T; Murakoshi H; Gatanaga H; Ternette N; Oka S; Borrow P; Takiguchi M
J Virol; 2019 Sep; 93(17):. PubMed ID: 31217245
[TBL] [Abstract][Full Text] [Related]
20. Rapid antigen processing and presentation of a protective and immunodominant HLA-B*27-restricted hepatitis C virus-specific CD8+ T-cell epitope.
Schmidt J; Iversen AK; Tenzer S; Gostick E; Price DA; Lohmann V; Distler U; Bowness P; Schild H; Blum HE; Klenerman P; Neumann-Haefelin C; Thimme R
PLoS Pathog; 2012; 8(11):e1003042. PubMed ID: 23209413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
